SCHEMBL7376502

SCHEMBL7376502

COCCOc1ccc(F)cc1CBr

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 4/20 0.40
KDM4E B2RXH2 1/20 0.40
HTR2C P28335 3/20 0.38
HTR2B P41595 3/20 0.38
HTR2A P28223 2/20 0.38
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 3/20 0.37
HTR1A P08908 1/20 0.36
MAPT P10636 1/20 0.36
FDPS P14324 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27518614 0.87 USP2 (0.40) USP2SMN1; SMN2L3MBTL1KDM4EHTR1A
SCHEMBL18977773 0.85 L3MBTL1 (0.51) USP2SMN1; SMN2L3MBTL1KDM4EHTR2A
SCHEMBL18783650 0.85 HTR2C (0.49) USP2SMN1; SMN2L3MBTL1KDM4EHTR2C
SCHEMBL18255267 0.83 CYP1A2 (0.42) SMN1; SMN2L3MBTL1KDM4EHTR2CHTR2B
SCHEMBL1663130 0.82 SLC6A2 (0.46) KDM4EHTR2CHTR2BHTR2AMEN1
SCHEMBL30200200 0.82 SLC6A2 (0.46) KDM4EHTR2CHTR2BHTR2AMEN1
SCHEMBL2904519 0.80 SLC6A2 (0.45) KDM4EHTR2CHTR2BHTR2AMEN1
SCHEMBL18860648 0.80 HTR2C (0.50) L3MBTL1KDM4EHTR2CHTR2BALDH1A1
SCHEMBL29580353 0.79 PKM (0.54) USP2SMN1; SMN2L3MBTL1KDM4EMEN1
SCHEMBL263614 0.79 PKM (0.54) USP2SMN1; SMN2L3MBTL1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1053224-B1 BIPHENYLSULFONYL CYANAMIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR UTILIZATION AS A MEDICAMENT AVENTIS PHARMA GMBH (DE) 2002-08-21 EP disclosed
US-6369069-B1 CARDIOVASCULAR DISORDERS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-04-09 US disclosed
EP-1053224-A1 BIPHENYLSULFONYL CYANAMIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR UTILIZATION AS A MEDICAMENT Aventis Pharma Deutschland GmbH (DE) 2000-11-22 EP disclosed
WO-1999040064-A1 BIPHENYLSULFONYL CYANAMIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR UTILIZATION AS A MEDICAMENT AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-08-12 WO disclosed